Literature DB >> 3096628

Facilitated detection of antibiotic-resistant Pseudomonas in cystic fibrosis sputum using homogenized specimens and antibiotic-containing media.

M Maduri-Traczewski, C L'Heureux, L Escalona, A Macone, D Goldmann.   

Abstract

Sputa from 30 patients with cystic fibrosis (CF) were cultured on routine and selective media plus three Mueller-Hinton antibiotic resistance screening plates containing tobramycin (5 micrograms/ml), azlocillin (100 micrograms/ml), and ticarcillin (100 micrograms/ml). In addition to direct semiquantitative plating, samples were homogenized for semiquantitative and quantitative culture. Blood agar plates from direct semiquantitative and homogenized semiquantitative cultures were then replica plated onto the antibiotic screening plates. Homogenized semiquantitative and quantitative cultures both detected more Pseudomonas aeruginosa strains than direct semiquantitative plating (103 versus 85 strains), including more antibiotic-resistant strains. Antibiotic screening media facilitated isolation of resistant strains and decreased detection time by 24 hr. Of the 103 strains on homogenized semiquantitative and quantitative cultures isolated before replica plating, 13 (13%) were tobramycin-resistant, 67 (65%) were ticarcillin-resistant, and 42 (41%) were azlocillin-resistant; 13 of 30 cultures (43%) had at least one tobramycin-resistant organism before replica plating. Replica plating detected an additional seven tobramycin-resistant and nine ticarcillin- or azlocillin-resistant strains in seven patients. Homogenization, antibiotic screening media, and replica plating enhance recognition of antibiotic-resistant strains in CF sputum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096628     DOI: 10.1016/0732-8893(86)90032-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  8 in total

1.  Microbiological processing of respiratory specimens from patients with cystic fibrosis.

Authors: 
Journal:  Can J Infect Dis       Date:  1993-05

2.  Comparison of four methods for pretreatment of cystic fibrosis sputa.

Authors:  J E Hoppe; J Holzwarth; M Stern
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

3.  Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosis.

Authors:  Jill M Van Dalfsen; Jenny R Stapp; Charles Phelps; Patricia Stewart; Jane L Burns
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

4.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

Review 5.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

6.  Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.

Authors:  G V Doern; B Brogden-Torres
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

7.  New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390).

Authors:  M E Campbell; S W Farmer; D P Speert
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  Infection control and the significance of sputum and other respiratory secretions from adult patients with cystic fibrosis.

Authors:  John E Moore; Adrienne Shaw; Jennifer L Howard; James S G Dooley; J Stuart Elborn
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-06-02       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.